Showing 13,941 - 13,960 results of 24,164 for search '(( 59 ((0 decrease) OR (a decrease)) ) OR ( 50 ((mean decrease) OR (we decrease)) ))', query time: 0.60s Refine Results
  1. 13941
  2. 13942
  3. 13943
  4. 13944
  5. 13945
  6. 13946

    The Effect of Discontinuing Continuous Glucose Monitoring in Adults with Type 2 Diabetes Treated with Basal Insulin by Grazia Aleppo (8550433)

    Published 2021
    “…</p> <p><b>Results: </b>In the group that discontinued CGM, mean time in range 70-180 mg/dL (TIR), which improved from 38% prior to initiating CGM to 62% after 8 months of CGM, decreased after discontinuing CGM to 50% at 14 months (mean change from 8 to 14 months = -12%, 95% CI -21% to -3%, P=0.01). …”
  7. 13947

    NRG1-II stimulates neurogenesis through ErbB4 as a cell-extrinsic signal. by Tomomi Sato (301255)

    Published 2015
    “…Impaired neurogenesis in MO<sup><i>erbb4atg</i></sup>-injected Tg(<i>pou4f1-hsp70l</i>:<i>GFP</i>) embryos at 50 hpf. Dotted circle, OT. Scale bar, 100 μm. <b>B</b>. …”
  8. 13948

    Expression of the ETS-5 target gene <i>gcy-9</i> restores CO<sub>2</sub>-chemosensitivity to <i>ets-5</i> mutants. by Julia P. Brandt (176082)

    Published 2012
    “…<i>N</i> = 3–5 populations of 30–50 animals. The <i>ets-</i>5 mutant strain used was FX1734. …”
  9. 13949

    Individual patient variability with the application of the kidney failure risk equation in advanced chronic kidney disease by Christopher McCudden (5374379)

    Published 2018
    “…Averaging of repeated measures of eGFR and ACR significantly decreased the variability (KFRE point estimate 17%, variability range 15% to 19%). …”
  10. 13950
  11. 13951
  12. 13952
  13. 13953

    DataSheet1_Diabetes outcomes in heart failure patients with hypertrophic cardiomyopathy.docx by Menatalla Mekhaimar (14103708)

    Published 2022
    “…Diabetes prevalence increased from 24.8% in 2005 to 32.7% in 2015. The mean age of patients with diabetes decreased from 71 ± 13 to 67.6 ± 14.2 (p < 0.01), but the prevalence of cardiovascular risk factors significantly increased. …”
  14. 13954

    Graphene Oxide Grid Preparation by Thomas G. Martin (2619529)

    Published 2016
    “…</p> <p>We identified that the type of grid, glow discharge conditions, graphene oxide flake size and concentration and deposition time all play a role in the final outcome. …”
  15. 13955

    Fig 5 - by Elżbieta Ziółkowska (12463173)

    Published 2022
    “…<p>Changes in mean beetle occupancy and abundance of B. lampros populations (plot of Abundance to Occupancy Relationship, AOR) in scenarios decreasing the insecticide toxicity and with DT<sub>50</sub> of (A) 25 days or (B) 1.3 days: (1) absolute changes, (2) relative changes in comparison to the baseline scenario (with LR of 90%, drift reduction of 50%, and no additional field margins added). …”
  16. 13956

    Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding Trial by John A. Todd (5933)

    Published 2016
    “…Furthermore, there was a dose-dependent down modulation of one of the two signalling subunits of the IL-2 receptor, the β chain (CD122) (mean decrease = 58.0%, SE = 2.8%, range 9.8%–85.5%, <i>n</i> = 33), on Tregs and a reduction in their sensitivity to aldesleukin at 90 min and day 1 and 2 post-treatment. …”
  17. 13957

    Pediatric Ocular Rosacea: Clinical Features and Long-Term Maintenance Therapy with Topical Cyclosporine by Gamze Özkan (22130419)

    Published 2025
    “…Delayed diagnosis was present in 10 patients, with a mean delay duration of 10.0 ± 2.7 months. Two patients showed recurrence and mean recurrence time was 6.50 ± 2.50 months. …”
  18. 13958
  19. 13959
  20. 13960